🔥Telegram İfşa

A new study finds in more than 2000 African women who had received a twice-yearly injection of the antiviral drug lenacapavir as pre-exposure prophylaxis (PrEP), not one contracted HIV. scim.ag/7Wd News from Science

Première rémission durable de l’infection par le VIH après greffe de moelle en l’absence de mutation protectrice ↘️pasteur.fr/fr/espace-pres… #VIH

Excite to share the case of Romuald, the Geneva patient, the first case of durable HIV remission (32 months and counting) following allogeneic stem cell transplant with wild-type CCR5 donor cells, just published (unedited version) in Nature Medicine. rdcu.be/dSHPt

nBregs & early-life microbiota Newborn regulatory B cells (nBreg) autocrinally regulate IgM via IL-10. mAbs from intestinal nBregs react against diverse bacteria, highlighting role of nBreg Abs in microbial diversity & early-life microbiota communities cell.com/cell-host-micr…

Le Pr Pierre Tiollais nous a quittés le 5 août 2024, à l'âge de 89 ans. Pionnier du génie génétique, il a réalisé des avancées majeures, dont le clonage et le séquençage du virus de l'hépatite B. L’Institut Pasteur a perdu une de ses figures emblématiques.

nBregs & early-life microbiota Newborn regulatory B cells (nBreg) autocrinally regulate IgM via IL-10. mAbs from intestinal nBregs react against diverse bacteria, highlighting role of nBreg Abs in microbial diversity & early-life microbiota communities cell.com/cell-host-micr…

Thank you to the Penn CFAR for inviting me to discuss our #HIV #vaccine candidate at the Penn CFAR Scientific Symposium. A fantastic session with Facundo Batista, The Drew Weissman Lab, Raiees Andrabi and George Shaw.

📍 Découvrez cet article "𝐋𝐞𝐬 𝐚𝐧𝐭𝐢𝐜𝐨𝐫𝐩𝐬 𝐈𝐠𝐀 𝐜𝐨𝐧𝐭𝐫𝐞 𝐥𝐞 𝐕𝐈𝐇-𝟏" tinyurl.com/n7cahy98 , le plus lu par les abonnés dans le dernier numéro de la revue 𝐕𝐢𝐫𝐨𝐥𝐨𝐠𝐢𝐞. Societe Francaise De Virologie #virologie #VIH1 #anticorps #lymphocytesb #Iga #muqueuses #bnAbs

Humoral immunity in HIV-1 post-treatment controllers : Current Opinion in HIV and AIDS journals.lww.com/co-hivandaids/…

Enhanced hepatitis B virus-specific immunity by combined... : Hepatology journals.lww.com/hep/abstract/9… 👏👏👏

Very happy to share a section on post-treatment HIV control for the January 2025 issue of Current Opinion on HIV/AIDS that I had the privilege of co-editing, together with Mirko Paiardini . We got a spectacular list of contributors: journals.lww.com/co-hivandaids/… @EraseHiv

In "Humoral immunity in HIV-1 post-treatment controllers" MOUQUET LAB reviews the emerging evidence of the role of antibodies on post-treatment control. journals.lww.com/co-hivandaids/…

From Feb '24: A treatment combining a soluble IL-15 superagonist with broadly neutralizing antibodies against the HIV-1 envelope protein induced long-term viral control in rhesus macaques infected with SIV-HIV. buff.ly/3ZZdYY4 #Immunology #HIV Science Magazine

To get 2025 off to a good start, I'm delighted to share with you our study published today in Nature Microbiology 🎉 We studied the ability of the receptor-binding proteins (RBP) of >100 animal viruses to mediate entry into human cells. A short thread below. nature.com/articles/s4156…

Rockefeller's Svetlana Mojsov has been named a recipient of the Frontiers of Knowledge Award from the Fundación BBVA for studies that laid the groundwork for a new generation of drugs used to treat type 2 diabetes and obesity. Congratulations! rockefeller.edu/news/37170-sve…

👏 Félicitations à Marcel Hollenstein Hollenstein group, chercheur à l’Institut Pasteur, lauréat du Prix Lebrasseur 2024, pour la contribution significative de ses travaux de recherche sur les acides nucléiques (ADN et ARN).

The last opus from the lab - kudos to @Luis_MAb and thanks to all collaborators, especially Eduard Baquero for his major contribution ! 🙏🙏🙏 Structural basis for hepatitis E virus neutralization by potent human antibodies | Science Advances science.org/doi/10.1126/sc…

Congrats to Rushad, Ursula, Johanna & colleagues !! 👏👏👏 In @elife: Somatic hypermutation patterns in immunoglobulin variable regions are established independently of the local transcriptional landscape doi.org/10.7554/eLife.…

1/3 Proud to share our work published in JCI insight focusing on antibodies to cancer. #MET is a long-known factor involved in cancer, and a target for #cancer therapy, but natural #Abs developed to this receptor during cancer were not described. insight.jci.org/articles/view/…

Another study from our lab💥🎊🍾 led by the super talented #MDPhD student Ron Yefet. He found a new target for neutralizing antibodies that attack #Mpox virus, discovered the mechanism and tested them in mice. A collab with Institut Pasteur, since 1887 Pablo GUARDADO-CALVO Olivier Schwartz Lab